Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Oct;56(4):501–504. doi: 10.1038/bjc.1987.233

Lung cancer and prior tuberculosis infection in Shanghai.

W Zheng 1, W J Blot 1, M L Liao 1, Z X Wang 1, L I Levin 1, J J Zhao 1, J F Fraumeni Jr 1, Y T Gao 1
PMCID: PMC2001820  PMID: 2825752

Abstract

In a population-based case-control study of lung cancer in Shanghai involving interviews during 1984-86 with 1,405 cancer patients and 1,495 controls, a significant 50% elevation in the risk of lung cancer, adjusted for cigarette smoking, was observed among persons who had a history of tuberculosis. Among those diagnosed with tuberculosis within the past 20 years, the risk exceeded 2.5-fold. In males the lung cancers tended to occur on the same side as the previous tuberculosis infection. For both sexes, the effect of recent tuberculosis was most apparent for adenocarcinoma and peripheral tumours. No relationship was found between lung cancer risk and the type of tuberculosis therapy, including use of isoniazid. The findings suggest that tuberculosis may predispose to lung cancer, with the association most apparent among recent survivors of the infection.

Full text

PDF
502

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach O., Garfinkel L., Parks V. R. Scar cancer of the lung: increase over a 21 year period. Cancer. 1979 Feb;43(2):636–642. doi: 10.1002/1097-0142(197902)43:2<636::aid-cncr2820430234>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  2. Bakris G. L., Mulopulos G. P., Korchik R., Ezdinli E. Z., Ro J., Yoon B. H. Pulmonary scar carcinoma. A clinicopathologic analysis. Cancer. 1983 Aug 1;52(3):493–497. doi: 10.1002/1097-0142(19830801)52:3<493::aid-cncr2820520319>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  3. Boice J. D., Fraumeni J. F., Jr Late effects following isoniazid therapy. Am J Public Health. 1980 Sep;70(9):987–989. doi: 10.2105/ajph.70.9.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell A. H., Guilfoyle P. Pulmonary tuberculosis, isoniazid and cancer. Br J Dis Chest. 1970 Jul;64(3):141–149. doi: 10.1016/s0007-0971(70)80002-x. [DOI] [PubMed] [Google Scholar]
  5. Clemmesen J., Hjalgrim-Jensen S. Is isonicotinic acid hydrazide (INH) carcinogenic to man? A 24-year follow-up of 3371 tuberculosis cases. Ecotoxicol Environ Saf. 1979 Dec;3(4):439–450. doi: 10.1016/0147-6513(79)90033-2. [DOI] [PubMed] [Google Scholar]
  6. Colditz G. A., Stampfer M. J., Willett W. C. Diet and lung cancer. A review of the epidemiologic evidence in humans. Arch Intern Med. 1987 Jan;147(1):157–160. doi: 10.1001/archinte.147.1.157. [DOI] [PubMed] [Google Scholar]
  7. Hammond E. C., Selikoff I. J., Robitzek E. H. Isoniazid therapy in relation to later occurrence of cancer in adults and in infants. Br Med J. 1967 Jun 24;2(5555):792–795. doi: 10.1136/bmj.2.5555.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hinds M. W., Cohen H. I., Kolonel L. N. Tuberculosis and lung cancer risk in nonsmoking women. Am Rev Respir Dis. 1982 Jun;125(6):776–778. doi: 10.1164/arrd.1982.125.6.776. [DOI] [PubMed] [Google Scholar]
  9. Howe G. R., Lindsay J., Coppock E., Miller A. B. Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients. Int J Epidemiol. 1979 Dec;8(4):305–312. doi: 10.1093/ije/8.4.305. [DOI] [PubMed] [Google Scholar]
  10. Koo L. C., Ho J. H., Lee N. An analysis of some risk factors for lung cancer in Hong Kong. Int J Cancer. 1985 Feb 15;35(2):149–155. doi: 10.1002/ijc.2910350202. [DOI] [PubMed] [Google Scholar]
  11. Steinitz R. Pulmonary tuberculosis and carcinoma of the lung. A survey from two population-based disease registers. Am Rev Respir Dis. 1965 Nov;92(5):758–766. doi: 10.1164/arrd.1965.92.5.758. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES